DMC Best Practices: What Biotechs and Sponsors Should Know
Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safety of an investigational product and at times the futility/efficacy. Successfully navigating DMC set-up, logistics, and independent data review can be complex, especially for biotech and smaller sponsors without in-house expertise.
Join us for this insightful webinar, where we will:
-
• Share best practices for establishing and running an effective Data Monitoring Committee (DMC)
-
• Explore the critical role of an Independent Data Analysis Centre (IDAC) in ensuring compliant, high-quality DMC operations.
-
• Present real-world case studies showcasing successful DMC implementation in high-stakes clinical trials
Date/Time: Thursday 11th September, 7am PDT / 10am EDT/ 3pm GMT
Learning Outcomes:
-
• How to establish and manage a DMC: Practical guidance on planning, roles, and documentation
-
• How IDACs support a DMC: Ensuring high-quality, independent, and compliant processes
-
• Best practices for running an efficient DMC: From interim analysis to meeting management and communication strategies
-
• Case study highlights: Real-world DMC scenarios, including multi-trial oversight and frequent meeting cycles
-
• Regulatory insights: What the FDA’s 2024 draft guidance means for DMC oversight and sponsor responsibilities
Meet the Experts:
Lucy Clark
Statistics Manager
With over 15 years of industry and academic experience; Lucy has worked on both safety and efficacy DMC studies, both as a voting member and internal unblinded DMC statistician.
Lisa Gibbons
Senior Statistician
With extensive industry DMC experience; Lisa has served as the DMC statistician, leading development of blinded and unblinded DMC reports.
Wei Liu
Associate Director of Biostatistics
With over 20 years of industry and academic experience; has worked as both independent and internal unblinded DMC statistician on many trials.
Matt George - Moderator
Senior Statistician
Matt is a Senior Statistician for Phastar with 4.5 years of industry experience. He has a keen interest in early phase designs, first carrying out research in the area as part of his Statistics Masters dissertation at Lancaster University.